Given that almost all EBV-positive nasopharyngeal carcinomas encode LMP1, the Ad-Δ LMP1-LMP2 gene was used to transduce dendritic cells in patients with advanced nasopharyngeal carcinoma and achieved satisfactory results in a clinical trial (168). This evidence concerns the gene PSMB9 and nasopharyngeal carcinoma.